Although there are multiple factors that could modulate glycolysis and functionality of NK cells in the TME38, an increased GLUT1 expression may mitigate the tumor-induced decrease of glycolytic activity due to a higher glucose uptake and thus be beneficial for NK cell functions. The gene discussed is SLC2A1; the disease is neoplasm.